Insider · CIK 0001810406
Elisabeth Bjork
Files at RCKT (ROCKET PHARMACEUTICALS, INC.), PHVS (Pharvaris N.V.). First filing Aug 27, 2025, latest Sep 21, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
PHVS: Pharvaris N.V.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
RCKT: ROCKET PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Pharvaris N.V. | $2.0M 52,500 shares | -78% | - | |
| 35Weak | RCKTbuy ROCKET PHARMACEUTICALS, INC. | $34k 10,000 shares | +33% | +42% from low-85% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock | +35,000 | $14.39 | $504k | 50,167 | 21 d ago |
| Sep 17, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock | +17,500 | $18.14 | $317k | 67,667 | 21 d ago |
| Sep 17, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock | -52,500 | $37.89 | $2.0M | 15,167 | 21 d ago |
| Sep 17, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | 21 d ago |
| Sep 17, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative | -17,500 | $0.00 | $0 | 0 | 21 d ago |
| Aug 27, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +10,000 | $3.41 | $34k | 40,000 | Aug 27, 2025 |
| Jun 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 30,000 | Jul 18, 2025 |
| Sep 26, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +607 | $0.00 | $0 | 607 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.